Optimizing urothelial cell preparation for the human urinary micronucleus assay

Area of Science:

• Biomarkers
• Genotoxicology
• Urothelial Carcinogenesis

Background:

• Biological monitoring for early cancer detection, like bladder carcinoma, shows promise using the urinary micronucleus (MNu) assay.
• Challenges in the MNu assay include poor differential cell staining, particularly with squamous cells in female urine samples.

Purpose of the Study:

• To optimize the urinary micronucleus (MNu) assay protocol for improved differential cell staining.
• To enhance the specificity and accuracy of genotoxic effect monitoring in urothelial cells.

Main Methods:

• Urine samples were fixed with Carnoy I and stained using the Papanicolaou method for differential cell visualization.
• The optimized protocol was tested on 10 subjects to differentiate urothelial (blue) and squamous (pink) cells.

Main Results:

• Differential staining successfully distinguished urothelial from squamous cells in urine samples.
• The optimized MNu assay allows for analysis from a single urine void in both males and females.
• Accurate distinction between cell types is crucial, as misclassification can mask genotoxic effects, particularly in women.

Conclusions:

• Restricting micronuclei analysis to urothelial cells provides a more precise cancer risk estimate.
• The improved MNu assay protocol enhances specificity and facilitates implementation in various settings.
• This optimized assay supports the use of micronuclei as a reliable biomarker for genotoxic effects and cancer risk assessment.